Day Zero Diagnostics
0 followers
‌
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.
Industries
Headquarters
Employees
Links
Org chart
Jong Lee
CEO & Cofounder
Jong Lee
Collapse
Miriam Huntley
Co Founder And CTO
Doug Kwon
Chief Scientific Officer
Melis Anahtar
Co-founder
Dougal Maclaurin
Scientific Co-founder
Dekel Gelbman
Senior Vice President, Business Development And Partnerships
Rene Robert
VP, Product Realization
Melodie Domurad
VP, Medical Affairs
Manoj Nair
Vice President, Molecular Assay Development
Melis Anahtar, MD, PhD
Co-Founder
